This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Neoplasms of unspecified nature or uncertain behav...
  • /
  • Myelodysplastic syndromes: ESMO Clinical Practice ...
Guideline

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:1st Jul 2014

Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders predominating in the elderly, with a median age at diagnosis of ~70 years. The aetiology of MDS is known in only 15% of cases. The first clinical practice guidelines from ESMO cover the diagnosis and management of these rare syndromes and also include information on cytomorphology, cytogenetics, prognosis and risk assessment and supportive care.

 

Read full guideline